BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Reilly CR, Babushok DV, Martin K, Spivak JL, Streiff M, Bahirwani R, Mondschein J, Stein B, Moliterno A, Hexner EO. Multicenter analysis of the use of transjugular intrahepatic portosystemic shunt for management of MPN-associated portal hypertension. Am J Hematol 2017;92:909-14. [PMID: 28543980 DOI: 10.1002/ajh.24798] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.2] [Reference Citation Analysis]
Number Citing Articles
1 Tamura K, Haruhara K, Azushima K, Iwamoto T, Wakui H. Possible interesting link between Janus kinase 2 mutation and renovascular hypertension. J Clin Hypertens (Greenwich) 2018;20:805-6. [PMID: 29656557 DOI: 10.1111/jch.13274] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
2 Abou-Ismail MY, Prchal JT, Deininger MW, Parker CJ, Lim MY. Anticoagulation management post-transjugular intrahepatic portosystemic shunt in portal hypertension associated with myeloproliferative neoplasms. Blood Coagul Fibrinolysis 2021;32:578-83. [PMID: 34608880 DOI: 10.1097/MBC.0000000000001087] [Reference Citation Analysis]
3 Liu J, Zhou B, Chen D, Zhou C, Shi Q, Zheng C, Feng G, Yuan F, Ge Y, Xiong B. Transjugular Intrahepatic Portosystemic Shunt Placement in Patients with Schistosomiasis-Induced Liver Fibrosis. Cardiovasc Intervent Radiol 2019;42:1760-70. [PMID: 31363898 DOI: 10.1007/s00270-019-02295-6] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
4 Stein BL, Martin K. From Budd-Chiari syndrome to acquired von Willebrand syndrome: thrombosis and bleeding complications in the myeloproliferative neoplasms. Hematology Am Soc Hematol Educ Program 2019;2019:397-406. [PMID: 31808903 DOI: 10.1182/hematology.2019001318] [Cited by in Crossref: 11] [Cited by in F6Publishing: 7] [Article Influence: 5.5] [Reference Citation Analysis]
5 Stein BL, Martin K. From Budd-Chiari syndrome to acquired von Willebrand syndrome: thrombosis and bleeding complications in the myeloproliferative neoplasms. Blood 2019;134:1902-11. [PMID: 31778549 DOI: 10.1182/blood.2019001318] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 4.5] [Reference Citation Analysis]
6 Akpan IJ, Stein BL. Splanchnic Vein Thrombosis in the Myeloproliferative Neoplasms. Curr Hematol Malig Rep 2018;13:183-90. [DOI: 10.1007/s11899-018-0446-x] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
7 Wada T, Yano Y, Yamamoto A, Kinoshita M, Yasutomi E, Hatazawa Y, Hayashi H, Shiomi Y, Yamashita K, Ueda Y, Kodama Y. Jejunal variceal rupture in a patient with myelofibrosis: a case report. Clin J Gastroenterol 2021;14:542-5. [PMID: 33675010 DOI: 10.1007/s12328-021-01373-y] [Reference Citation Analysis]